A higher concentration can make it much more difficult to measure out a precise dose, especially if your research requires very small amounts
We critically evaluate every intervention lifestyle, medication, or procedure and include it only when benefits outweigh risks and costs, and you are fully informed
Anna Lembke, a Stanford University addiction medicine specialist, told The Associated Press that while some clinicians are already prescribing GLP-1s off-label for addiction, the drugs dont work the same way for everyone and carry risks, including gastrointestinal side effects, pancreatitis and kidney conditions, that must be weighed
Careful titration or dose adjustments, updated or combination formulations, and drugs targeting side effects are all strategies being deployed to improve the palatability of GLP-1s